Contribution of 18-fluorodeoxyglucose positron emission tomography (FDG PET) imaging in the detection of underlying carcinoma in a woman with nonspecific mastitis
Abstract
Introduction. Differentiation between a malignancy and inflammatory process is still a diagnostic challenge. Mammography (MG) and ultrasonography (US) have low sensitivity and specificity in dense breasts in order to detect malignancy. On the other hand, malignant mass lesions can also be masked on magnetic resonance imaging (MRI) by diffuse inflammatory process. 18-fluorodeoxyglucose positron emission tomography (FDG PET) imaging can be a promising alternative imaging method in the evaluation of suspicious breast masses, especially in patients with accompanying inflammatory breast diseases. Case report. We report an atypical case of a patient suspected for malignancy in right breast on physical examination and radiologic findings in favor of mastitis. Neither MG nor US revealed any mass lesion consistent with malignancy. Moreover, MRI findings were primarily considered as infectious or granulomatous mastitis. However, FDG PET determined the accurate borders of tumor and dissemination of breast cancer with superiority to other conventional radiological methods. Conclusion. This case report emphasizes the contribution of FDG PET imaging to other conventional radiological methods with regard to primary tumor diagnosis, determination of the biopsy site, and also staging the disease especially in patients with accompanying inflammatory breast disease.
Introduction. Differentiation between a malignancy and inflammatory process is still a diagnostic challenge. Mammography (MG) and ultrasonography (US) have low sensitivity and specificity in dense breasts in order to detect malignancy. On the other hand, malignant mass lesions can also be masked on magnetic resonance imaging (MRI) by diffuse inflammatory process. 18-fluorodeoxyglucose positron emission tomography (FDG PET) imaging can be a promising alternative imaging method in the evaluation of suspicious breast masses, especially in patients with accompanying inflammatory breast diseases. Case report. We report an atypical case of a patient suspected for malignancy in right breast on physical examination and radiologic findings in favor of mastitis. Neither MG nor US revealed any mass lesion consistent with malignancy. Moreover, MRI findings were primarily considered as infectious or granulomatous mastitis. However, FDG PET determined the accurate borders of tumor and dissemination of breast cancer with superiority to other conventional radiological methods. Conclusion. This case report emphasizes the contribution of FDG PET imaging to other conventional radiological methods with regard to primary tumor diagnosis, determination of the biopsy site, and also staging the disease especially in patients with accompanying inflammatory breast disease.
References
References
Rieber A, Tomczak RJ, Mergo PJ, Wenzel V, Zeitler H, Brambs HJ. MRI of the breast in the differential diagnosis of mastitis versus inflammatory carcinoma and follow-up. J Comput As-sist Tomogr 1997; 21(1): 128–32.
Kocaoglu M, Somuncu I, Ors F, Bulakbasi N, Tayfun C, Ilkbahar S. Imaging Findings in Idiopathic Granulomatous Mastitis. J Comput Assist Tomogr 2004; 28(5): 635–41.
Gunalp B, Ince S, Karacalioglu AO, Ayan A, Emer O, Alagoz E. Clinical impact of (18)F-FDG PET/CT on initial staging and therapy planning for breast cancer. Exp Ther Med 2012; 4(4): 693–8.
Cheng L, Reddy V, Solmos G, Watkins L, Cimbaluk D, Bitterman P, et al. Mastitis, a Radiographic, Clinical, and Histopatholog-ic Review. Breast J 2015; 21(4): 403–9.
Liong YV, Hong GS, Teo JG, Lim GH. Breast ductal carcinoma in situ presenting as recurrent non-puerperal mastitis: Case re-port and literature review. World J Surg Oncol 2013; 11(1): 179.
Uematsu T. MRI findings of inflammatory breast cancer, local-ly advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast can-cer. Breast Cancer 2012; 19(4): 289–94.
Jari I, Naum AG, Ursaru M, Manafu EG, Gheorghe L, Negru D. Breast infections: Diagnosis with ultrasound and mammogra-phy. Rev Med Chir Soc Med Nat Iasi 2015; 119(2): 419–24.
Giess CS, Chikarmane SA, Sippo DA, Birdwell RL. Breast MR Imaging for Equivocal Mammographic Findings: Help or Hin-drance? Radiographics 2016; 36(4): 943–56.
Wang L, Wang D, Fei X, Ruan M, Chai W, Xu L, et al. A rim-enhanced mass with central cystic changes on MR imaging: How to distinguish breast cancer from inflammatory breast diseases? PLoS ONE 2014; 9(3): e90355.
Baslaim MM, Bakheet SM, Bakheet R, Ezzat A, El-Foudeh M, Tulbah A. 18-Fluorodeoxyglucose-positron emission tomogra-phy in inflammatory breast cancer. World J Surg 2003; 27(10): 1099–104.
Hancerliogullari O, Arslan N, Gorgulu S, Can MF, Ayan EH, Ince S, et al. 2-[18f ]-Fluoro-2-deoxy-d-glucose positron emission tomography in the evaluation of breast lesions and axillary in-volvement: A comparison with mammography and histo-pathological diagnosis. Turk J Med Sci 2012; 42(Suppl 1): 1214–21.
Bakheet SM, Powe J, Kandil A, Ezzat A, Rostom A, Amartey J. F-18 FDG uptake in breast infection and inflammation. Clin Nucl Med 2000; 25(2): 100–3.
Alberini J, Lerebours F, Wartski M, Fourme E, Le SE, Gontier E, et al. 18F-fluorodeoxyglucose positron emission tomogra-phy/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer. Cancer 2009; 115(21): 5038–47.